AbioMed
| Cardiology Network |
 Discuss AbioMed further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
AbioMed is a Danvers, Massachusetts, Massachusetts-based company that builds the AbioCor Artificial Heart, the first fully implanted device of its kind. The AbioCor was approved for Humanitarian Use on September 5, 2006.
External links
- FDA Approval Press Release September 5, 2006.